ATE336990T1 - 2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen - Google Patents
2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzenInfo
- Publication number
- ATE336990T1 ATE336990T1 AT01130638T AT01130638T ATE336990T1 AT E336990 T1 ATE336990 T1 AT E336990T1 AT 01130638 T AT01130638 T AT 01130638T AT 01130638 T AT01130638 T AT 01130638T AT E336990 T1 ATE336990 T1 AT E336990T1
- Authority
- AT
- Austria
- Prior art keywords
- indanylamino
- treatment
- derivatives
- chronic
- acute
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01130638A EP1321139B1 (de) | 2001-12-21 | 2001-12-21 | 2-Indanylaminoderivate zur Therapie von chronischen, akuten oder entzündlichen Schmerzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE336990T1 true ATE336990T1 (de) | 2006-09-15 |
Family
ID=8179649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01130638T ATE336990T1 (de) | 2001-12-21 | 2001-12-21 | 2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050222266A1 (de) |
| EP (2) | EP1321139B1 (de) |
| JP (1) | JP4427329B2 (de) |
| AT (1) | ATE336990T1 (de) |
| BR (1) | BR0207371A (de) |
| CA (1) | CA2470990C (de) |
| DE (1) | DE60122541T2 (de) |
| DK (1) | DK1321139T3 (de) |
| ES (1) | ES2270947T3 (de) |
| HU (1) | HUP0402664A3 (de) |
| MX (1) | MXPA04005884A (de) |
| NO (1) | NO20033670L (de) |
| NZ (1) | NZ533537A (de) |
| PL (1) | PL207015B1 (de) |
| PT (1) | PT1321139E (de) |
| SI (1) | SI1321139T1 (de) |
| WO (1) | WO2003053429A2 (de) |
| ZA (1) | ZA200404845B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ565416A (en) * | 2005-07-28 | 2011-03-31 | Chiesi Farma Spa | Therapeutic combination comprising a NMDA receptors blocker and a narcotic analgesic substance |
| KR102014203B1 (ko) | 2011-02-18 | 2019-08-26 | 아사나 바이오사이언시스 엘엘씨 | 아미노인단 화합물 및 통증 치료에서 그것의 용도 |
| US9044482B2 (en) | 2012-08-15 | 2015-06-02 | Asana Biosciences, Llc | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2115792C (en) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
| IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
| AU7472898A (en) * | 1997-05-07 | 1998-11-27 | Algos Pharmaceutical Corporation | Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain |
| NZ515143A (en) * | 1999-06-10 | 2004-05-28 | Bridge Pharma Inc | Aminoindane piperidine compounds as dermal anesthetic agents |
-
2001
- 2001-12-21 DK DK01130638T patent/DK1321139T3/da active
- 2001-12-21 ES ES01130638T patent/ES2270947T3/es not_active Expired - Lifetime
- 2001-12-21 DE DE60122541T patent/DE60122541T2/de not_active Expired - Lifetime
- 2001-12-21 AT AT01130638T patent/ATE336990T1/de active
- 2001-12-21 PT PT01130638T patent/PT1321139E/pt unknown
- 2001-12-21 EP EP01130638A patent/EP1321139B1/de not_active Expired - Lifetime
- 2001-12-21 SI SI200130651T patent/SI1321139T1/sl unknown
-
2002
- 2002-12-06 WO PCT/EP2002/013839 patent/WO2003053429A2/en active IP Right Grant
- 2002-12-06 JP JP2003554186A patent/JP4427329B2/ja not_active Expired - Fee Related
- 2002-12-06 US US10/498,350 patent/US20050222266A1/en not_active Abandoned
- 2002-12-06 PL PL370763A patent/PL207015B1/pl not_active IP Right Cessation
- 2002-12-06 NZ NZ533537A patent/NZ533537A/en not_active IP Right Cessation
- 2002-12-06 CA CA2470990A patent/CA2470990C/en not_active Expired - Fee Related
- 2002-12-06 BR BR0207371-4A patent/BR0207371A/pt not_active IP Right Cessation
- 2002-12-06 MX MXPA04005884A patent/MXPA04005884A/es active IP Right Grant
- 2002-12-06 EP EP02790474A patent/EP1455771B1/de not_active Expired - Lifetime
- 2002-12-06 HU HU0402664A patent/HUP0402664A3/hu unknown
-
2003
- 2003-08-19 NO NO20033670A patent/NO20033670L/no not_active Application Discontinuation
-
2004
- 2004-06-18 ZA ZA200404845A patent/ZA200404845B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4427329B2 (ja) | 2010-03-03 |
| WO2003053429A2 (en) | 2003-07-03 |
| EP1455771B1 (de) | 2006-11-08 |
| NO20033670D0 (no) | 2003-08-19 |
| MXPA04005884A (es) | 2004-11-01 |
| EP1321139A1 (de) | 2003-06-25 |
| EP1455771A2 (de) | 2004-09-15 |
| AU2002366727A1 (en) | 2003-07-09 |
| US20050222266A1 (en) | 2005-10-06 |
| PL207015B1 (pl) | 2010-10-29 |
| JP2005513101A (ja) | 2005-05-12 |
| ES2270947T3 (es) | 2007-04-16 |
| NO20033670L (no) | 2003-10-21 |
| DE60122541T2 (de) | 2007-09-13 |
| SI1321139T1 (sl) | 2007-02-28 |
| EP1321139B1 (de) | 2006-08-23 |
| HUP0402664A2 (hu) | 2005-04-28 |
| HUP0402664A3 (en) | 2012-05-29 |
| WO2003053429A3 (en) | 2003-07-31 |
| DE60122541D1 (de) | 2006-10-05 |
| NZ533537A (en) | 2006-08-31 |
| BR0207371A (pt) | 2004-02-10 |
| CA2470990A1 (en) | 2003-07-03 |
| CA2470990C (en) | 2011-03-29 |
| ZA200404845B (en) | 2006-07-26 |
| PL370763A1 (en) | 2005-05-30 |
| PT1321139E (pt) | 2007-01-31 |
| DK1321139T3 (da) | 2007-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60323077D1 (de) | Immobilisierung und stabilisierung von viren | |
| EA200201012A1 (ru) | Способы стерилизации биологических материалов | |
| MY141003A (en) | Materials and methods for treating viral infections with a cysteamine compound | |
| DE60230869D1 (de) | 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen | |
| BRPI0509140A (pt) | processos para o tratamento de infecção por hiv | |
| BRPI0417322A (pt) | combinações de substáncias ativas com propriedades inseticidas | |
| BRPI0410029B8 (pt) | composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto | |
| EA200000911A1 (ru) | Новые кристаллические формы антивирусного соединения бензимидазола | |
| DE602006020775D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von manie und bipolaren störungen | |
| DE50110618D1 (de) | Verwendung von MEK-Inhibitoren zur Herstellung eines Arzneimittels gegen Negativstrang-RNA-Viren Infektionen | |
| ATE486634T1 (de) | Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza | |
| EA200200137A1 (ru) | Лечение невротических нарушений | |
| DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
| HUP0200152A2 (hu) | KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| ATE442155T1 (de) | Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids | |
| ATE336990T1 (de) | 2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen | |
| DE502005001365D1 (de) | Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und/oder Pelargonium Reniforme | |
| ATE478679T1 (de) | Verfahren zur anwendung von ionisierungsstrahlung bei einer hiv-infektionstherapie | |
| ATE398134T1 (de) | Neue analoga von nitrobenzylthioinosin | |
| DE60236443D1 (de) | Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie | |
| BR0211533A (pt) | Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas | |
| DE50207436D1 (de) | Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten | |
| ATE374202T1 (de) | Neue analoga von nitrobenzylthioinosin | |
| DE602004016547D1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| ATE544453T1 (de) | Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1321139 Country of ref document: EP |